Dermtech (NASDAQ: DMTK) is an upstart healthcare company that's revolutionizing the way skin care is detected -- with a simple patch rather than a biopsy. In this segment of "The 5," recorded on Nov. 23, Fool contributors Connor Allen and Jason Hall discuss Dermtech and how that skin-cancer-detection innovation could lead to multi-bagging returns. Jason Hall: Connor, how about you go next?
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting